Introduction
Carbon nanotubes (CNTs) are likely to participate in many new ground-breaking advances in nanomedicine including drug/gene delivery, tissue regeneration, bio-sensing, probes for diagnostics or monitoring, among many others. 1 CNTs are also interesting tools for therapeutic delivery since they can move across most cellular barriers, interact with tissues in living organisms, finally translocating inside the cells, where they interact with different organelles and proteins. [2] [3] [4] These intrinsic properties of CNTs have a great potential if they are exploited in biotechnology. [5] [6] [7] [8] [9] Among CNTs, multiwalled carbon nanotubes (MWCNTs) display unique biomimetic properties with microtubules 10, 11 that are well-established targets for many anticancer drugs such as taxol®. 12 Microtubules are highly dynamic intracellular tubulin protein nanotubes that play a central role in cell division and migration. These protein filaments and MWCNTs (i) selfassemble, (ii) have analogous dimensions, (iii) are exceptionally resilient and finally, (iv) show comparable extraordinary structural and surface properties (i.e. shear stress, bending stiffness, Young´s modulus). 10, 13, 14 Similarities between MWCNTs and microtubules prompt their interaction in vitro 15 and in vivo 11, 16 and the assembly of mixed bio-synthetic intracellular polymers that display an enhanced stability compared to conventional tubulin polymers. 11 This interaction triggers critical changes in the cellular biomechanics resulting in anti-proliferative, 11 anti-migratory 17, 18 and cytotoxic 19 effects in cancer cells in vitro, as well as significant anti-tumoral effects in vivo. 20 These results suggest CNTs could have a potential application as adjuvant or neoadjuvant therapies in the development of future anti-cancer agents. 21 Unfortunately, despite these interesting results, there is a long way before MWCNTs can be applied to humans. Their potential long-term effects due to tissue damage and accumulation are key issues to control and improve. Among the unwanted side effects in healthy cells and tissues, MWCNTs trigger: inflammatory reactions, cytotoxicity, DNA breakage, chromosomal mal-segregation, etc. [22] [23] [24] [25] [26] Thus, the "Achilles heels" for the potential applications of MWCNTs as nanomedicines is the complete inactivation and/or clearance of these nanomaterials after therapy. The discovery of CNT bio-degradation in vitro by phagocytic cells has opened new opportunities. These cells have an extraordinary degradative potential, and can break down virtually all kinds of biomolecules captured by the endocytic or phagocytic entry routes. Their lysosomes, apart from displaying a pH of 4.5, contain a large variety of enzymes (acid-hydrolases and peroxidases) that are able to gradually digest CNTs. [27] [28] [29] [30] [31] [32] [33] Macrophages, 32 microglia, [33] [34] [35] [36] neutrophils 37, 38 and eosinophils 31 have all been confirmed to degrade CNTs in culture after different previous surface treatments. Paradoxically, phagocytes are more susceptible than other cells to CNT-toxicity, at least in vitro. 19, 39 Their avidity to capture these foreign materials often results in the production of intolerable levels of superoxides and hydroxyl radicals involved in the oxidative stress reaction triggered during CNT degradation. 25, 32, 35, [40] [41] [42] Some studies support the idea that reaching an equilibrium between phagocyte nanotube intake and clearance is critical to prevent tissue bioaccumulation and damage. But improving MWCNT biodegradation is not a trivial task. These fibres are some of the strongest and stiffest materials and thus, they are highly stable under standard in vivo physiological conditions. Their bio-persistence depends on (i) the number of walls of the nanotube, (ii) the surface and diameter of the tubes, (iii) the dose, (iv) route of administration and finally, (v) their surface functionalisation. 24, 26, [43] [44] [45] [46] Interestingly, several studies show how CNT degradation by biological enzymes is significantly enhanced when the nanotube surface is chemically modified by oxidation. 34, 35, 45, [47] [48] [49] [50] [51] This treatment results in the formation of different functional groups on the CNT surface, and structural defects in the nanotube walls that serve as macrophage enzymatic "attack" sites for wall degradation. Based on these findings, we have explored various surface oxidation pre-treatments to enhance MWCNT clearance by macrophages preserving their biomimetic properties with microtubules, in ultimate term responsible for their antiproliferative, anti-migratory and cytotoxic effects in cancer cells.
Results and discussion
MWCNT oxidation pre-treatment.
To improve intracellular CNT degradation, pristine MWCNTs (pMWCNTs) were oxidized in a v/v = 3/1 mixture of H 2 SO 4 /HNO 3 at 37º C for two different periods of time (2 and 9 h, as indicated). As described elsewhere, 52 this treatment generates the formation of functional groups such as -C-OH groups that can be transformed into -C=O groups on the outer surface of the oxidized MWCNTs (o-MWCNTs). To characterize this process and to obtain valuable information about the structure, composition and surface adsorbed molecules and defects on oMWCNTs we employed transmission electron microscopy (TEM) and Raman spectroscopy to characterize the degree of structural defects/changes and to monitor the different vibrational active modes produced by the oxidation processes (see also Fig. S1 ). 53, 54 TEM imaging of the p-MWCNTs and the 9h o-MWCNTs (Fig. 1a ) revealed defects including: (i) a reduction of the number of walls, from 12-16 walls in pristine sample to 8-10 average carbon layers in o-MWCNTs, (ii) changes in the outer and inner walls, (iii) layer exfoliation, (iv) small surface imperfections and finally, (v) wall bending or breaks. This technique also served to demonstrate a general good preservation of the o-MWCNTs (i.e. diameter and length, see below). Raman spectroscopy, yields key information of the purity and defects of the MWCNTs, allowing the identification of this type of nanotubes among other carbon compounds. In particular, the measurement of the integrated intensity ratio between the D and G bands (A D /A G ) is a way to semi-quantify the degree of structural defects in the nanotube sample (Table 1) . 33, 34, 36, 45, 55, 56 Fig. 1b displays representative Raman spectra of p-MWCNT, 2 and 9 h pre-oxidized MWCNT samples showing the characteristic D and G bands at ca. 1350 cm -1 and 1590 cm -1 , respectively. These bands represent a good fingerprint of the graphitization of the sample, where the D band is assigned to the presence of disorder, and the G band corresponds to the tangential vibrations of carbon atoms along the layer. The D´ band, at ca. 1615 cm -1 can also be observed as a shoulder attached to the G band. Interestingly, the G band shifts towards lower wavenumbers with longer oxidation treatments indicating the charge transfer produced by the processes of oxidation and degradation modifying the charge at the MWCNT surface. 57, 58 Based on these studies, we compared the A D /A G integrated intensity ratios of p-MWCNTs, 2 h and 9 h oMWCNTs to estimate the degree of surface defects triggered by the oxidation pre-treatment on the surface of the nanotubes samples. Results summarized in Table 1 confirmed a relationship between the oxidation time and the structural defects on the surface of the nanotubes, validating the effectiveness of the applied treatment. MWCNTs used as anti-tumoral agents should normally be degraded at the tumour site by the tumour-associatedmacrophages and/or local stromal cells. Thus, to evaluate the improved biodegradation of MWCNTs bundles inside these cells, we used phase contrast microscopy on immortalized macrophages exposed to 5 µg/mL of 2 h and 9 h o-MWCNTs in the culture medium. As Fig. S2 shows, macrophages exposed during 72 h to 9 h o-MWCNTs displayed a significant reduction of the intracellular black-carbon masses compared to identical cells exposed to 2 h o-MWCNTs. As observed by other authors, 59 MWCNT oxidation was also accompanied by an improved phagocyte survival rate (Fig. S2c) . The intracellular degradation process was verified using other techniques. To further confirm intracellular o-MWCNT degradation, we extracted nanotubes from the cells exposed to 9 h o-MWCNTs or p-MWCNTs during 96 h (see the Experimental section). Extracted nanotubes were compared to the as prepared original nanotubes characterised in Fig. 1 , and the nanotubes present in the culture medium where macrophages were growing (see the experimental diagram in Fig. S3 ). Nanotubes extracted from cells, the culture media and the as prepared material were photographed using TEM ( 
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o-MWCNT display biomimetic anticancer cytotoxic effects in vitro.
We now tested the anti-cancer cytotoxic effects of o-MWCNTs on HeLa cells following previously published protocols.
11
Confocal microscopy examination of 50 µg/mL o-MWCNT treated cell cultures served to confirm sings indicative of the biomechanical disruptive effect of these nanotubes on HeLa, including: (i) cell retraction, (ii) membrane blebbing, (iii) nuclear DNA compaction, (iv) presence of micronuclei (Figs. 3a -white  asterisks, S5) , as well as other previously described cytoskeletal changes including a disorganized microtubular patterns or a reactive cortical actin. 18 Interestingly, many cells presented long extra-cellular actin/tubulin-coated extensions, measuring 10-15 µm, similar to those shown to contain MWCNTs in previous studies (red-green arrows).
11 Similar experiments were also performed in parallel on malignant cancer cells. For this purpose we selected the B16-F10 murine cell line, a multiresistant malignant melanoma that displays an aggressive nature, is genetically heterogeneous and is highly metastatic (Fig S6) . The anti-tumoral effects of o-MWCNTs were tested on solid melanoma tumours produced by transplantation of B16-F10 cells. This system model is highly representative of most malignant tumours, being characterized by local acidosis, oedema and abundant tumour-associated supporting stromal cells that include macrophages. 60, 61 To improve reproducibility, solid pigmented melanoma tumours were injected only once with 2 µg of serum-functionalised nanotubes resuspended in a saline solution containing antibiotics (see the Experimental section). Intra-tumoral injection experiments were performed systematically in total population of more than 150 transplanted mice (see below) that were sacrificed 4 days postinjection. As a control, we injected the resuspension medium in sibling mice obtained from the same litter. Results shown in MWCNT-treated tumours significant (t= 1.5; n= 146, Fig. 3d ). This anti-tumoral effect was undistinguishable to that observed in mice injected with p-MWCNTs (t= 0.2; n= 161). Finally, the biodegradability of the injected nanotubes at the tumoral organ was evaluated using Raman spectroscopy. Semi-quantification of the A D /A G bands in peritumoral and intratumoral tissue sections revealed a significant degradation of the injected oMWCNTs in situ, 18 and 15 days after injection respectively, while no significant changes were observed for p-MWCNTs as these time points (Fig. 4) . Summarizing, here we present a bio-compatibilization method that can be used to improve the risk-to-benefit ratio of MWCNTs for their potential used as nanomedicines against cancer, either as adjuvant or as neoadjuvant therapies. Moreover, identical pre-treatments can be used for nanotubes used as surface coatings in the assembly of multi-structured nanodelivery carrier devices to improve intracellular cytoplasmic targeting. 
Experimental MWCNT oxidation and characterization.
High-purity MWCNT obtained from Nanocyl NC3100™ were dispersed by sonication for 5 minutes in a 3:1 mixture of H 2 SO 4 (98%)/HNO 3 (65%) and were incubated at 37º C under continuous shaking. 26, 45 Resulting as prepared MWCNTs were fully characterised by Raman and IR spectroscopy, TGA, mass spectrometry and TEM (Fig. S1 ). Samples were taken at 2 or 9 h. The acid solution was removed by filtration through a 0.45 µm and were washed in H 2 O until pH ~7. o-MWCNTs were dispersed and functionalised with serum-containing culture medium as previously described. 11 Final working solutions were centrifuged 2 min. at 10,000 g to remove micrometric aggregates before concentration determination by optical absorption at 550 nm. Raman spectra were taken with a Horiba T64000 triple spectrometer in the backscattering geometry, a 647 nm line of a Coherent Innova Spectrum 70c Ar + -Kr + laser and a nitrogen-cooled CCD (Jobin-Yvon Symphony). A confocal microscope was used for the intracellular sample Raman spectra detection focusing the laser beam into a 1 µm 2 with a 100x objective as described in previous studies. 11 MWCNT were identified using unique fingerprints characterizing a number of well-defined resonances 55 such as the dispersive disorder induced D band, the tangential G and the D' band, which are attributed using the symmetry analysis to the longitudinal optical mode (LO) close to Brillouin zone centre (Γ). 62 The Dband representing the asymmetrical properties of the tubes (structural defects), and the G-band the planar carbon atom vibrations (linear structure). Raman features such as the radial breaching modes (RBM), associated with a small diameter inner tube (less than 2 nm), are usually too weak to be observable in these large diameter tubes. 63, 64 As for previous studies, the ratio between the areas of the intensity the D and G peaks (A D /A G ) were used to characterize the structural disorganization that MWCNTs undergo during oxidation and intracellular degradation. [32] [33] [34] 45 The average intensities of more than 10 spectra for each time and MWCNT type and experimental time are represented in histograms of Fig. 2c . Transmission electron microscopy was performed in a JEOL JEM 2100 operated at 120 kV on ethanol-dispersed samples adsorbed onto a Lacey copper grid. Infrared spectra were recorded on a Jasco LE4200 spectrophotometer. TGA was carried out using a Setaram Setsys Evolution 1700 apparatus, ranging from ca 20 -900º C. Samples were placed into platinum crucibles. Measurements were performed in nitrogen atmosphere with a heating rate of 10 º C/min at a total flow rate of 20 mL/min. A mass spectrometer, Pfeiffer OmniStar Prisma, attached to the TG equipment allowed us to follow the exhausted CO 2 gas.
Cell culture and viability studies.
HeLa and murine macrophage cells (J774) were grown in cultured with Eagle's Minimum Essential Medium (EMEM, Biowhittaker™) and Iscove's Modified Dulbecco's Medium (IMDM) respectively, containing 10% FBS, and were kept in standard conditions. HeLa and J774 cells were exposed to 50 and 5 µg/mL respectively. Live/dead cell assessment was performed automatically using a trypan blue assay (SigmaAldrich) on a Bio-Rad TC-20 cell counter at the indicated times. An average of 540,000 macrophage cells were automatically counted for each condition.
MWCNT isolation from cells/medium.
Macrophage cells were exposed to nanotubes in the culture medium for 96 h before extraction. Identical amounts of cells (ca. 9 x 10 6 cells of each) and culture medium (500 µL of medium originally containing 50 µg/mL of nanotubes) were used for nanotube isolation. After cell pelleting, the culture media containing the resuspended MWCNTs and the cell pellets were processed in parallel for direct comparison. Samples were treated successively with 1% Triton X100 phosphate buffered saline (PBS), 35% HCl and acetone.
Statistical analysis.
A two-tailed t-test was used in all other statistical analysis. Significance was stablished for a p= 0.05 (*) or a p= 0.01 (**).
Imaging studies.
Cells were fixed with 4% paraformaldehyde. Actin was stained with Phalloidin-Tetramethylrhodamine B isothiocynate and the DNA with Hoechst dye (both from Sigma-Aldrich®). Microtubules were immunostained with B512 anti-α-tubulin antibody (Sigma-Aldrich®) and a secondary goat anti-mouse IgG antibody conjugated with Alexa Fluor 488 (Molecular probes®). Confocal and phase contrast images were taken using a Nikon A1R confocal microscope. Image processing was performed with the NIS-Elements Advanced Research software. Fluorescent images are pseudo-coloured.
o-MWCNT tumour growth studies in vivo.
Tumorigenesis was induced by subcutaneous transplantation of a total of 2x10 5 B16-F10 melanoma cells in 10 µL of culture medium containing antibiotics following previously described procedures. 64 Animal experimentation procedures were performed according to EU legislation. All animal procedures were performed in accordance with the Guidelines for Care and Use of Laboratory Animals of The University of Cantabria and approved by the Animal Ethics Committee of this University. Solid pigmented tumours were single treated 7 days posttransplant with a unique dose of 2 µg of o-MWCNTs resuspended in a volume of 10 µL of culture medium. To reduce natural artefacts, littermates were injected in parallel with oMWCNTs or the resuspension medium used as excipient. Tumours masses were carefully dissected and weighed 4 days post injection. Statistical analysis was performed using a t-test. The confidence levels and total number of events included in the study (n) are indicated in the figures. Quantitative results are expressed as mean values with their corresponding standard deviation error bars.
In conclusion, here we demonstrate o-MWCNT biodegradation in cultured cells and in vivo, at the tumoral site in mice bearing malignant tumours produced by transplantation. Biodegradation is detectable a few days after these nanotubes have had a therapeutic effect. This new property can serve to synergistically improve the already existing traditional microtubule-stabilizing chemotherapies such as taxol®, but also to enhance the in vivo degradation of carbon nanotubes as key components in the design of novel nanocarrier devices for their use in therapeutic fields other than cancer.
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